Position in DHR
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,740,054
-$61,475 QoQ
Shares Held
14,385
-2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#787
of 2,098 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Mediolanum International Funds Ltd holds $60,319,527 across 7 Diagnostics & Research names. DHR ranks #4 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
41,323 | $21,754,080 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
37,630 | $18,866,176 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
10,001 | $12,776,377 | |
| 4 | DHR |
Danaher Corp /De/
This page
|
14,385 | $2,740,054 | |
| 5 | A |
Agilent Technologies, Inc.
|
12,625 | $1,676,978 | |
| 6 | ILMN |
Illumina, Inc.
|
7,467 | $1,312,922 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
6,174 | $1,192,940 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,740,054 | 14,385 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,801,529 | 14,776 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,553,296 | 15,522 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,001,259 | 15,138 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,832,723 | 14,340 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,604,095 | 22,459 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,646,401 | 15,885 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,612,629 | 16,591 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,006,744 | 20,039 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $24,829,909 | 99,431 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||